Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Growth · New York Life Investments

NYLI Epoch Capital Growth Fund Class A (MECDX)

Ticker MECDX · Since 2016-06-30 · · Holdings as of Jul 31, 2026

Expense ratio
1.15%$115/yr per $10k
5-yr return
+9.2%annualized
1-yr return
+7.2%as of Dec 2025
Net assets
$133.7Mall share classes
Holdings
115

Bottom line

Is MECDX a good fund? The bottom line

MECDX is the Class A share class of NYLI Epoch Capital Growth Fund, a managed large growth mutual fund from New York Life Investments.

It charges 1.15% — about $115 a year on every $10,000 invested, more expensive than 74% of large growth funds we track.

It returned +7.2% over one year, +9.2% a year over five years (as of Dec 31, 2025, per its prospectus).

With $134 million in net assets and 115 holdings, its largest position is NVIDIA Corp. (3.9%) and the top 10 make up 20.7% of the portfolio.

This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.

What to watch

  • Expensive for its category (1.15%)
  • Front-end sales load up to 5.5%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What MECDX invests in

The Fund seeks long-term capital appreciation.

"The Fund generally invests in a diversified portfolio consisting of equity securities of companies located throughout the world, including the United States, that have a history of earning a high return on their invested capital relative to their cost of capital and that have positive growth in operating cash flow. Under normal circumstances, the Fund invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of companies across all market capitalizations. Equity securities include, among others, common stocks, depositary receipts, master limited partnerships, real estate investment trusts, warrants, and rights. The Fund may invest up to 20% of its net assets in securities issued by companies in emerging markets as determined by the Fund's Subadvisor, Epoch Investment Partners, Inc., when it believes those securities represent…

From the fund's prospectus (filed Feb 26, 2026).

MECDX performance

Average annual total returns
1 yr5 yr10 yr
MECDX+7.2%+9.2%—
Large Growth median+15.2%+11.0%+14.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MECDX performance history →

What MECDX costs

On a $10,000 investment, MECDX's 1.15% expense ratio costs about $115 a year. The prospectus estimates $1,970 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.

See the full MECDX fee table →

MECDX top 10 holdings

#Holding% of fund
1NVIDIA Corp.3.91%
2Apple, Inc.2.53%
3Taiwan Semiconductor Manufacturing Co. Ltd.2.07%
4Monster Beverage Corp.1.86%
5Alphabet, Inc.1.77%
6West Pharmaceutical Services, Inc.1.76%
7Applied Materials, Inc.1.76%
8Broadcom, Inc.1.72%
9EMCOR Group, Inc.1.69%
10Medpace Holdings, Inc.1.65%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 20.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to MECDX

More funds like MECDX →

MECDX FAQ

What is the expense ratio of MECDX?
MECDX's expense ratio is 1.15%, which works out to about $115 a year for every $10,000 invested. The prospectus estimates total costs of $1,970 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MECDX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.15%); front-end sales load up to 5.5%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does MECDX hold?
MECDX's largest holdings are NVIDIA Corp. (3.9%), Apple, Inc. (2.5%), Taiwan Semiconductor Manufacturing Co. Ltd. (2.1%), Monster Beverage Corp. (1.9%), Alphabet, Inc. (1.8%). It holds 115 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is MECDX's 5-year return?
MECDX returned +9.2% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does MECDX have a sales load?
Yes. MECDX has a maximum front-end sales charge of 5.5%.
Who manages MECDX?
MECDX is offered by New York Life Investments through New York Life Investments Funds Trust.